about
Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells.Different stages of pluripotency determine distinct patterns of proliferation, metabolism, and lineage commitment of embryonic stem cells under hypoxia.Kinetic and metabolic analysis of mouse embryonic stem cell expansion under serum-free conditions.Monitoring the ex-vivo expansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy.A Fully-Closed and Automated Hollow Fiber Bioreactor for Clinical-Grade Manufacturing of Human Mesenchymal Stem/Stromal Cells.Large-scale expansion of mouse embryonic stem cells on microcarriers.Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells.Integrated culture platform based on a human platelet lysate supplement for the isolation and scalable manufacturing of umbilical cord matrix-derived mesenchymal stem/stromal cells.Scale-up of mouse embryonic stem cell expansion in stirred bioreactors.A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue.Scalable ex vivo expansion of human mesenchymal stem/stromal cells in microcarrier-based stirred culture systems.Microcarrier Culture Systems for Stem Cell ManufacturingMaximizing mouse embryonic stem cell production in a stirred tank reactor by controlling dissolved oxygen concentration and continuous perfusion operationEffect of hypoxia on proliferation and neural commitment of embryonic stem cells at different stages of pluripotencyDelta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of ConceptA xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cellsModulation of the in vitro angiogenic potential of human mesenchymal stromal cells from different tissue sourcesFunctional comparison of beating cardiomyocytes differentiated from umbilical cord-derived mesenchymal/stromal stem cells and human foreskin-derived induced pluripotent stem cellsAddressing the Manufacturing Challenges of Cell-Based Therapies
P50
Q38928264-3008F938-9F3D-49FE-B075-8B16A09D4326Q39694788-8211DBEB-4AB2-43F8-B2AB-190AA5B10788Q39808684-355000DF-FC0F-477D-89B5-B774C520F882Q40173940-7575F320-1DDC-4A87-AF60-EC80724E1667Q48213538-765E526F-56BA-48DC-A25B-E73BE99678C2Q50659967-21CDEA7D-3338-4E75-95D3-B0E72DB929A7Q51313343-A15AE728-B2AE-46F8-924A-4C1D6381BC5DQ51335986-D85DDF9E-4175-4296-A8BD-9F72B8E0ABFFQ53063065-2A557C7D-99AA-4189-B0AA-972E8BFB2730Q53229865-D9534E44-F99D-42D5-AEA2-641CDA946170Q53443164-4991B908-3D49-4B77-8131-A273CB6F488AQ53490878-3D1B91DE-27DF-4AC3-B1B9-D75A8ACFC038Q59062478-411DF52B-C953-4DB2-8A1F-F786A9689721Q59062724-E0E297BA-92C2-48BA-821F-156C2D23753FQ59062902-6B832375-9984-4B32-84B2-4864DE4DCF40Q61787508-F7A66D6E-A7F1-404A-B7BE-732F72A69F29Q87091256-CB887DF8-F7D9-4EF5-80B9-2A47B03DF067Q89617007-5265EA4C-A8EF-452C-A85C-BE84ECCFD0E5Q91213229-4897D882-3F64-4459-AEB3-FBAD118A5957Q92031080-E260ABFD-B0A7-44F7-AD32-888805B5CCD7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana Fernandes-Platzgummer
@ast
Ana Fernandes-Platzgummer
@en
Ana Fernandes-Platzgummer
@es
Ana Fernandes-Platzgummer
@nl
type
label
Ana Fernandes-Platzgummer
@ast
Ana Fernandes-Platzgummer
@en
Ana Fernandes-Platzgummer
@es
Ana Fernandes-Platzgummer
@nl
prefLabel
Ana Fernandes-Platzgummer
@ast
Ana Fernandes-Platzgummer
@en
Ana Fernandes-Platzgummer
@es
Ana Fernandes-Platzgummer
@nl
P106
P1153
35749894500
P21
P31
P496
0000-0002-5367-6528